−0.050AUD
−6.18 MAUD
730.34 KAUD
90.94 M
About PROTEOMICS INTERNATIONAL LABORATORIES LTD
Sector
Industry
CEO
Richard Lipscombe
Website
Headquarters
Perth
Founded
2001
ISIN
AU000000PIQ0
FIGI
BBG007HW1G08
Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company was founded by Richard Lipscombe and Bill Parker in 2001 and is headquartered in Perth, Australia.
$PIQ cr at 77 this week. Right on support.Lots of newsflow on this thing coming. Ive drawn a speculative red curve. These raises inevitably test the raise price and double whammy with director Dick selling shares.
Having said that I reckon they'll have great newsflow this year and Europe agreements should be the highest priority along
$PIQ - Proteomics International continuing its rapid climb$PIQ - Proteomics International continuing its rapid climb
Good little stock with lots of momentum. All my indicators are headed in the right direction - probably a bit expensive at the moment based on the RSI - but with diabetes being the next big global disease especially in the western world Ill
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PIQ is 1.085 AUD — it has decreased by 2.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PROTEOMICS INTERNATIONAL LABORATORIES LTD stocks are traded under the ticker PIQ.
PROTEOMICS INTERNATIONAL LABORATORIES LTD is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
PIQ stock is 4.63% volatile and has beta coefficient of 0.63. Check out the list of the most volatile stocks — is PROTEOMICS INTERNATIONAL LABORATORIES LTD there?
Yes, you can track PROTEOMICS INTERNATIONAL LABORATORIES LTD financials in yearly and quarterly reports right on TradingView.
PIQ stock has fallen by 5.24% compared to the previous week, the last month showed zero change in price, over the last year PROTEOMICS INTERNATIONAL LABORATORIES LTD has showed a 24.71% increase.
PIQ net income for the last quarter is −3.75 M AUD, while the quarter before that showed −2.15 M AUD of net income which accounts for −74.71% change. Track more PROTEOMICS INTERNATIONAL LABORATORIES LTD financial stats to get the full picture.
Today PROTEOMICS INTERNATIONAL LABORATORIES LTD has the market capitalization of 145.29 M, it has increased by 10.22% over the last week.
No, PIQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PIQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROTEOMICS INTERNATIONAL LABORATORIES LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROTEOMICS INTERNATIONAL LABORATORIES LTD technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROTEOMICS INTERNATIONAL LABORATORIES LTD stock shows the buy signal. See more of PROTEOMICS INTERNATIONAL LABORATORIES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PROTEOMICS INTERNATIONAL LABORATORIES LTD future price: according to them, PIQ price has a max estimate of 1.38 AUD and a min estimate of 1.38 AUD. Read a more detailed PROTEOMICS INTERNATIONAL LABORATORIES LTD forecast: see what analysts think of PROTEOMICS INTERNATIONAL LABORATORIES LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROTEOMICS INTERNATIONAL LABORATORIES LTD EBITDA is −7.51 M AUD, and current EBITDA margin is −1.05 K%. See more stats in PROTEOMICS INTERNATIONAL LABORATORIES LTD financial statements.